Search results
Results From The WOW.Com Content Network
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. It is also listed on the American Nasdaq and is a Nasdaq-100 company. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide. [14]
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Chinese authorities have detained five current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector.
Custom in-house solutions were developed by a few individual laboratories, while some enterprising entities sought to develop commercial reporting solutions in the form of special instrument-based systems. [1] In 1982 the first generation of LIMS was introduced in the form of a centralized minicomputer, which offered automated reporting tools.
AstraZeneca is advancing early stage trials of several cell therapies in different types of cancer including liver and prostate cancer. (Reporting by Sriparna Roy in Bengaluru; Editing by Shounak ...
On April 23, 2007, it was announced MedImmune and AstraZeneca entered into a definitive agreement under which AstraZeneca intended to acquire MedImmune in an all-cash transaction at US$ 58 per share, or about US$ 15.2 billion. [6] On 19 June 2007 AstraZeneca completed the acquisition paying US$ 15.
A woman working for Wells Fargo in Arizona died at work and was found four days later, authorities have confirmed. Denise Prudhomme, 60, last clocked in at the Wells Fargo in Tempe at 7 a.m. on ...
In March 2020, Novo volunteers started testing samples for SARS-CoV-2 with RT-qPCR equipment in the ongoing coronavirus pandemic to increase available test capacity. [27] In June, the business announced it would acquire AstraZeneca 's spin-off Corvidia Therapeutics for an initial sum of $725 million (up to a performance-related maximum of $2.1 ...